Experimental Hematology

Papers
(The median citation count of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis56
RNA methylation: where to from here for hematologic malignancies?53
Corrigendum to ’ 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9’ [Volume 114, October 2022, Pages 43-53.e2]33
IFC: Editorial Board32
From drosophila to humans: a journey through macrophage development26
Epidemiology of Chronic Lymphocytic Leukemia in Sardinia, Italy (1974–2003)21
3163 – MODULATION OF RNA POLYMERASE II ACTIVITY REGULATES HUMAN HSC SELF-RENEWAL20
3168 – DEATH MODELS OF HEMATOPOIESIS: NEW TRANSGENIC MOUSE MODELS ENABLING PAN-HEMATOPOIETIC OR SELECTIVE HEMATOPOIETIC STEM CELL DEPLETION IN VIVO17
3010 – REJUVENATING BLOOD STEM CELLS EXTENDS LIFESPAN OF AGED IMMUNOCOMPROMISED MICE16
3175 – TUNEABLE HYDROGELS AS A NEW TOOL TO EXPLORE EXTRACELLULAR MATRIX PROTEINS IN MALIGNANCY16
3047 – SRCAP MUTATION PROMOTES LYMPHOID BIAS IN THERAPY-RELATED CLONAL HEMATOPOIESIS15
3054 – CROSSTALK AT THE MATERNAL-FETAL INTERFACE CONSTRAINS FETAL HEMATOPOIETIC STEM AND PROGENITOR CELL RESPONSE TO INFLAMMATION.14
3091 – CLINICAL FEATURES AND MOLECULAR BASIS OF THALASSEMIC PATIENTS WITH HOMOZYGOTE FORM OF IVSII-I/ IVSII-I MUTATION AND SYNCHRONIZATION WITH Α-GENE MUTATION14
3062 – SICKLE CELL DISEASE COMPROMISES THE HEMATOPOIETIC STEM CELL BONE MARROW NICHE WITH AGE14
3183 – COORDINATE ACTIVATION OF IL-1Β-INDUCED GLYCOLYSIS AND HIF1⍺ STABILIZATION DRIVES TET2-DEFICIENT CLONAL EXPANSION13
3124 – NOVEL REGULATORY MECHANISM OF HEMOGENIC ENDOCARDIUM DURING CARDIOVASCULAR DEVELOPMENT12
3181 – ERYTHROPOIETIN SUPPORTS SURVIVAL AND SELF-RENEWAL OF PRIMARY HUMAN MEGAKARYOCYTIC-ERYTHROID PROGENITORS, BUT DOES NOT INSTRUCT LINEAGE COMMITMENT12
3077 – FUNCTIONAL AND MOLECULAR IDENTIFICATION OF A FETAL-ASSOCIATED TUMOR SUPPRESSOR AXIS: ABROGATION OF MLL-ENL DRIVEN ACUTE MYELOID LEUKEMIA12
3185 – FROM STEM CELL TO MEGAKARYOCYTE: DELINEATING LINEAGE COMMITMENT IN MURINE MEGAKARYOPOIESIS USING SINGLE-CELL RNA-SEQ12
3132 – IDENTIFICATION OF SIGNALLING-RESPONSIVE CIS-REGULATORY ELEMENTS REGULATING BLOOD DEVELOPMENT12
3188 – MODELING HEMATOPOIETIC PHENOTYPE OF HUMAN RPA1 MUTATIONS12
3198 – HUMAN PLURIPOTENT STEM CELL-DERIVED MACROPHAGES FOR MODELLING MYCOBACTERIAL INFECTION11
3219 – RNA DEADENYLATION SUBUNIT CNOT3 PROMOTES MYELOID LEUKEMIA BY DRIVING TRANSLATION OF ONCOGENIC TARGETS11
3228 – FUNCTIONAL INVESTIGATION OF THE ARGONAUTE PROTEINS IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS11
3199 – MULTI-OMICS ANALYSIS REVEALS DYSFUNCTIONAL EPIGENETIC REGULATION IN HEMATOPOIETIC STEM CELL AGING11
3239 – DETERMINING THE MECHANISM BY WHICH RUNX1 LOSS LEADS TO AN INFLAMMATORY RESPONSE IN HEMATOPOIETIC CELLS11
3193 – EXPRESSION OF CD61 MARKS FUNCTIONALLY DISTINCT POPULATIONS OF AGED HEMATOPOIETIC STEM CELLS11
3224 – NFAT TRANSCRIPTION FACTORS ARE REQUIRED FOR DEFINITIVE HEMATOPOIESIS11
Cover 2: Editorial Board11
3016 – SPATIAL TRANSCRIPTOMICS AT EARLY STAGES OF LEUKEMIA PROGRESSION IDENTIFIES A POPULATION OF PROLIFERATIVE AML CELLS MARKED BY DPP4 EXPRESSION10
Cover 2: Editorial Board10
Cover 2: Editorial Board10
1023 – UNRAVEL THE ROLE OF THE VASCULAR NICHE IN THE LEUKEMIC MICROENVIRONMENT10
IFC Editorial Board10
Cover 2: Editorial Board10
1006 – TRANSCRIPTIONAL ALTERATIONS AND ONTOGENY IN PEDIATRIC ACUTE MYELOID LEUKEMIA10
IFC Editorial Board10
3046 – REDUCING HYPERACTIVATED BAP1 ATTENUATES MUTANT ASXL1-DRIVEN MYELOID MALIGNANCIES IN HUMAN HEMATOPOIETIC CELLS9
3043 – CHARACTERIZATION OF THE OSTEOCYTE-REGULATED MICROENVIRONMENTAL INFLUENCES ON B CELL DEVELOPMENT USING TWO-PHOTON IMAGING9
3057 – NOVEL IMMUNE CELL SUBSETS REVEALED USING THE FGD5 REPORTER MOUSE9
3066 – Β-CATENIN PROMOTES AN RNA BIOGENESIS TRANSCRIPTIONAL PROGRAM IN T-ALL9
3055 – REGULATION OF PROTEIN SYNTHESIS IN LEUKEMIA STEM CELLS9
3062 – A ZEBRAFISH MODEL OF GRANULIN DEFICIENCY REVEALS ESSENTIAL ROLES IN MYELOID CELL DIFFERENTIATION9
1014 – CELLULAR SENESCENCE: AN UNINTENDED TWIST FOR GENE AND CELL THERAPY APPLICATIONS8
3092 – CDK6 IN HEMATOPOIETIC STEM CELLS: MORE THAN A CELL CYCLE KINASE8
2022 – A NICHE-DIRECTED THERAPEUTIC APPROACH TARGETING MDS AND AML8
2015 – PHARMACOLOGICALLY-INDUCED TRANSCRIPTION FACTOR RE-PU-SITIONING IN ACUTE MYELOID LEUKEMIA8
Author Index8
1019 – DECIPHERING THE HEMATOPOIETIC CELL ECOSYSTEM IN DISEASES8
3094 – AGGRESSIVE NK CELL LEUKEMIA IN A CAUCASIAN PATIENT8
2008 – VEGF-INDUCED VASCULAR PERMEABILITY RESULTS IN DRASTIC AND REVERSIBLE HEMATOPOIETIC STEM CELL MOBILIZATION8
2025 – HAEMATOPOIETIC STEM CELL CLONAL DYNAMICS ACROSS THE HUMAN LIFESPAN8
2023 – INFLAMMATION-RESPONDING MESENCHYMAL STROMAL CELLS MODULATE THE BONE MARROW MICROENVIRONMENT RESPONSE TO STRESS OVER TIME.8
1022 – GENE THERAPY FOR BETA-THALASSEMIA: FROM THE BENCH TO THE BEDSIDE AND BACK8
1006 – MOLECULAR TO TISSUE-SCALE ANALYSIS OF HEMATOPOIETIC STEM/PROGENITOR CELL DYNAMICS8
2003 – HSPC INFUSION ENHANCES SURVIVAL FROM GAS SEPSIS BY BOOSTING IMMUNOMODULATORY CELLS.8
3071 – HEALTHY AND MALIGNANT HEMATOPOIETIC STEM CELLS ACT AS IMMUNOREGULATORY ANTIGEN PRESENTING CELLS8
3126 – HEMATOPOIETIC STEM CELLS WITH LYMPHOID BIAS ARE MARKED BY CD49B7
3112 – GROWTH FACTOR INDEPENDENCE 1 EXPRESSION INDUCED METABOLIC VULNERABILITIES AND PRESENTS NOVEL THERAPEUTIC OPPORTUNITIES IN ACUTE MYELOID LEUKAEMIA7
3103 – NITRIC OXIDE-DEPENDENT VASODILATION MAINTAINS THE PHYSIOLOGICAL OXYGEN LEVELS IN BONE MARROW AND ALLOWS LOCAL CRAWLING OF HEMATOPOIETIC STEM CELLS7
3139 – INVESTIGATING THE ROLES OF WASP IN MEGAKARYOCYTES AND PATHOGENESIS OF THROMBOCYTOPENIA IN WISKOTT-ALDRICH SYNDROME USING ISOGENIC PLURIPOTENT STEM CELL MODELS6
3019 – SINGLE-CELL PROTEO-GENOMIC REFERENCE MAPS OF THE HEMATOPOIETIC SYSTEM ENABLE THE PURIFICATION AND MASSIVE PROFILING OF PRECISELY DEFINED CELL STATES6
3083 – INVESTIGATING THE IMPACT OF JAK2 V617F MEGAKARYOCYTES ON MYELOFIBROSIS IN AN IPS CELL MODEL6
2007 – IDENTIFICATION AND ISOLATION OF HEMATOPOIETIC STEM CELLS AND PROGENITORS WITH DISCRETE DEVELOPMENTAL GENE EXPRESSION PROGRAMS.6
3125 – HETEROGENEITY IN EXPRESSION OF ENDOSOMAL PROTEINS ARISES IN MOUSE EMBRYONIC HEMATOPOIESIS AND IS MAINTAINED DURING HSC AGING6
2004 – GERMLINE ANKRD26 MUTATIONS IN FAMILIAL THROMBOCYTOPENIA AND LEUKEMIA PREDISPOSITION6
3027 – GENERATION OF A CD43 FLUORESCENT REPORTER IPSC LINE TO TRACK HEMATOPOIETIC DEVELOPMENT6
3136 – LOSS OF CD36 EXPRESSION HAS LIMITED IMPACT ON NORMAL HEMATOPOIESIS6
2002 – LIVE SINGLE CELL QUANTIFICATION OF GATA SWITCH DYNAMICS DURING ADULT AND DEVELOPMENTAL ERYTHROPOIESIS IDENTIFY NOVEL REGULATORY MECHANISMS OF ERYTHROPOIESIS6
3133 – DIRECT COMPARISON OF IMPROVED METHOD FOR HUMAN INDUCED PLURIPOTENT STEM CELL (IPSC) HAEMATOPOIETIC DIFFERENTIATION SHOWS ENHANCED EFFICIENCY AND SENSITIVITY AT REDUCED COST6
3022 – METABOLIC AND EPIGENETIC IMPACT OF CD44 ANTIBODY-INDUCED DIFFERENTIATION IMPLICATES THE USE OF EPIGENETIC THERAPIES IN AML TREATMENT6
3109 – SPLICING AND TRANSCRIPTIONAL ELONGATION REGULATION OF HEMATOPOIETIC STEM AND PROGENITOR CELL EMERGENCE6
3145 – TRANSIENT EXPRESSION OF HEMATOPOIETIC TRANSCRIPTION FACTORS ENHANCES T CELL POTENTIAL OF HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED HEMATOPOIETIC PROGENITORS6
3039 – OXIDIZED 5-METHYLCYTOSINE MODULATES SYNTHETIC LETHALITY TO POLY-ADP-RIBOSE POLYMERASE INHIBITORS IN ACUTE MYELOID LEUKEMIA6
3004 – SINGLE-CELL ANALYSIS REVEALS THAT CLUSTERIN-POSITIVE HEMATOPOIETIC STEM CELLS WITH IMPAIRED STEMNESS EXPAND WITH AGING5
3115 – THE COLLAGEN-MODIFYING LYSYL HYDROXYLASE, PLOD2, IS REQUIRED FOR HEMATOPOIETIC STEM CELL SPECIFICATION5
3152 – IDENTIFYING SELECTIVE REGULATORS OF HEMATOPOIETIC STEM CELLS IN DEVELOPMENT5
2012 – DNMT3A-MUTANT HEMATOPOIETIC PROGENITOR CELLS INDUCE SENESCENCE OF BONE MARROW STROMA TO ACCELERATE CLONAL HEMATOPOIESIS AND TRANSFORMATION TO ACUTE MYELOID LEUKEMIA5
3029 – COMBINATORIAL GENE TARGETING IN PRIMARY HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS5
3025 – UNCOVERING THE ROLE OF KDM5C IN NORMAL HEMATOPOIESIS5
3105 – IMPACT OF DACH1 DOWNREGULATION ON MLL-AF4 INFANT LEUKEMOGENESIS5
3098 – RUNX1/RUNX1T1 ORCHESTRATES THE LEUKAEMIC MICROENVIRONMENT5
3005 – AGING ATTENUATES THE HEMATOPOIETIC STEM CELL CONTRIBUTION TO NATIVE HEMATOPOIESIS5
3020 – RNA-INTERFERENCE SCREEN IDENTIFIES MTA1 AS A REGULATOR OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS5
3151 – SINGLE-CELL RNA SEQUENCING ANALYSIS REVEALS ROLE FOR GATA3 IN THE AORTIC ENDOTHELIUM AT THE TIME OF HEMATOPOIETIC STEM CELL EMERGENCE5
3112 – IMPACT OF IMMUNOPROTEASOME INHIBITION IN MOUSE MODEL OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS5
3142 – HEMATOPOIETIC STEM CELLS MARGINALLY PARTICIPATE IN EMERGENCY HEMATOPOIESIS5
3009 – THERAPEUTIC TARGETING OF RNA DEGRADATION PATHWAYS- NEW AVENUES FOR INTERVENTION IN ACUTE MYELOID LEUKAEMIA5
3087 – KINETICS OF PERIPHERAL BLOOD AND LIVER ERYTHROCYTES DURING EXPOSURE TO COLD IN AFRICAN CLAWED FROGS, XENOPUS LAEVIS4
3096 – ALTERNATIVE SPLICING AND THE RBP KHDRBS1 REGULATE HEMATOPOIETIC STEM AND PROGENITOR CELL FORMATION4
3185 – PROTEOMIC ANALYSIS OF TERMINAL ERYTHROPOIESIS IN THE SF3B1 MUTATION MOUSE MODEL4
3015 – DELETION OF THROMBOSPONDIN-1 PRESERVES HEMATOPOIETIC STEM CELL HEALTHSPAN DURING AGING4
3034 – CH-ASSOCIATED DNMT3A MUTATIONS MODIFY THE EXPRESSION OF GENES WITH REPRESSIVE HISTONE MARKS4
3107 – EFFECTS OF DIFFERENT MUTATIONS CAUSING CLONAL HAEMATOPOIESIS4
3189 – ELEVATED CLONAL HEMATOPOIESIS SEEN IN WTC 9/11 FIRST RESPONDERS HAS DISTINCT AGE-RELATED PATTERNS AND RELIES ON IL1RAP FOR CLONAL EXPANSION4
3218 – GENETIC DETERMINANTS OF REGULATED PROTEIN SYNTHESIS DEPENDENCY IN LEUKEMIA STEM CELLS4
3215 – TWO NOVEL ENHANCERS OF CDKN1A ARE EPIGENETICALLY REGULATED BY THE CHROMATIN ASSEMBLY FACTOR 1 AND CEBPA IN ACUTE MYELOID LEUKEMIA4
3016 – CCR1 AS A POTENTIAL THERAPEUTIC TARGET FOR AML IN THE ELDERLY4
3203 – PROTEIN TYROSINE PHOSPHATASE PRL2 PROMOTES MLL-AF9 DRIVEN LEUKEMOGENESIS VIA INHIBITING THE P53 PATHWAY4
3181 – CRISPR/CAS9-MEDIATED CORRECTION OF FANCC GENE RESCUES THE INDUCED BONE MARROW FAILURE IN FANCC-/- MOUSE4
3052 – EXTRINSIC SASH1 SIGNALING PROMOTES HEMATOPOIETIC STEM CELL GENERATION DURING EMBRYOGENESIS4
3140 – DELINEATING HEMATOPOIETIC AND CARDIAC MESODERMAL FATES FROM HPSCS4
3197 – NMEMK COLONY-FORMING CELLS IN HUMAN UMBILICAL CORD BLOOD4
3079 – CANCER-ASSOCIATED FIBROBLASTS (CAFS) AND THE PRELEUKEMIC BONE MARROW NICHE4
3135 – CD34+CD19-CD22+ B-CELL PROGENITORS MIGHT UNDERLIE PHENOTYPIC ESCAPE IN PATIENTS TREATED WITH CD19-DIRECTED THERAPIES4
3124 – GRANULOCYTE COLONY-STIMULATING FACTOR MODIFIES THE IN VITRO DIFFERENTIATION OF HUMAN PRIMITIVE ERYTHROID PROGENITOR CELLS4
3066 – IDENTIFICATION AND CHARACTERIZATION OF NEW MULTIPOTENT PROGENITORS IN ADULT HUMAN HEMATOPOIESIS4
3059 – THE ABSENCE OF PROSTASIN LEADS TO IMPAIRED TERMINAL EMBRYONIC ERYTHROID DIFFERENTIATION3
3180 – ENDOTHELIAL CELL-SPECIFIC LOSS OF RETINOIC ACID RECEPTOR GAMMA ACTIVITY HAS SEX-DEPENDENT EFFECTS ON HEMATOPOIEISIS AND PREDISPOSES FEMALE MICE TO ACQUIRED BONE MARROW FAILURE3
3204 – CD83 MARKS ACUTE INFLAMMATORY STRESS ACTIVATION IN HUMAN HEMATOPOIETIC STEM CELLS AND ITS DEPLETION RESTRAINS INFLAMMATION RESPONSE3
A Tribute to Hal Broxmeyer (1944–2021)3
3033 – DIFFERENTIAL RESPONSES AND RECOVERY DYNAMICS OF HAEMATOPOIETIC POPULATIONS FOLLOWING PLASMODIUM CHABAUDI INFECTION3
2026 – A CANCER IMMUNOTHERAPY MODALITY BASED ON DENDRITIC CELL REPROGRAMMING IN VIVO3
3032 – DEVELOPING A TRACTABLE EX VIVO MODEL OF HUMAN HAEMATOPOIESIS3
3136 – CLASSICAL MYELOID PROGENITORS DEMONSTRATE AGE-RESISTANCE THROUGHOUT LIFE3
3070 – IMPLICATING THE SPOC DOMAIN OF RBM15 IN RBM15-MKL1 FUSION PROTEIN-INDUCED ACUTE MEGAKARYOBLASTIC LEUKEMIA3
3173 – THE REGULATORY ROLE OF SERUM RESPONSE FACTOR IN ERYTHROPOIESIS3
3104 – FITNESS IS A BETTER PREDICTOR OF OUTCOMES IN CLONAL HEMOPOIESIS COMPARED TO CLONE SIZE3
3187 – IKAROS LOSS ENHANCES PRE-LEUKEMIC THYMOCYTE SELF-RENEWAL AND DRIVES T-ALL IN MICE3
3126 – PERSISTENT METABOLIC DEFLATION OF HEMATOPOIETIC STEM CELLS (HSCS) AFTER CHEMOTHERAPY CAUSES PREMATURE HEMATOPOIETIC AGEING3
1025 – RIBOSOMES AS DETERMINANTS OF CELL IDENTITY AND FUNCTION3
Serum metabolomic profiling correlated with ISS and clinical outcome for multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation3
1021 – RNA REGULATORS OF CELLULAR FATE3
3194 – CLONAL HEMATOPOIESIS-ASSOCIATED DNMT3A MUTATIONS CAUSE INCREASED T CELL ACTIVATION AND DECREASED LEUKEMIC TUMOR BURDEN3
3219 – VASCULAR ENDOTHELIAL GROWTH FACTOR-INDUCED VASCULAR PERMEABILITY RESULTS IN DRASTIC AND REVERSIBLE HEMATOPOIETIC STEM CELL MOBILIZATION3
3160 – MYCN IS AN ESSENTIAL IMMATURE T-ALL ONCOGENIC DRIVER MARKED BY BROAD H3K4ME33
2007 – INFORMING THERAPEUTIC APPROACHES FOR P53 DEFECTIVE BLOOD CANCERS3
3060 – BONE MARROW MESENCHYMAL STEM CELLS RELY ON VASCULAR CELL ADHESION MOLECULE-1 FOR SURVIVAL AND NICHE MAINTENANCE3
2005 – THE MITOCHONDRIAL ELECTRON TRANSPORT CHAIN IS A THERAPEUTIC VULNERABILITY IN DNMT3A-MUTANT CLONAL HEMATOPOIESIS3
3055 – ENHANCING TRANSLATION FIDELITY EXTENDS HEMATOPOIETIC STEM CELL LONGEVITY3
1007 – GENOMIC REPETITIVE ELEMENTS SIGNAL SURFACE B2M TO BLOCK PHAGOCYTOSIS OF HSCS3
2003 – PHYSICALLY INTERACTING CELL SEQUENCING IN BONE MARROW FIBROSIS REVEALS DISTINCT CELLULAR NICHES IN FIBROSIS3
3024 – RESTRAINT OF TGF-B SIGNALING BY SMAD7 IS NECESSARY FOR HEMATOPOIETIC STEM CELL FORMATION IN THE MOUSE EMBRYO3
3146 – MITOCHONDRIAL ACTIVITY DICTATES DEFINITIVE HEMATOPOIETIC STEM CELL PRODUCTION AND LYMPHO-MYELOID LINEAGE SEGREGATION DURING MOUSE EMBRYOGENESIS3
3085 – BROCCOLI EXTRACT MITIGATES CRYOPRESERVATION-INDUCED MITOCHONDRIAL DYSREGULATION IN CORD BLOOD CELLS3
3134 – UNDERSTANDING MAJOR DRIVERS OF AGE-INDUCED PLATELET DYSREGULATION AND THROMBOSIS3
3029 – MITOCHONDRIAL REGULATION OF CELL FATE THROUGH BIOGENESIS OF EXTRACELLULAR VESICLES IN HSC3
IFC Editorial Board3
3159 – A SINGLE-CELL PROTEIN-TRANSCRIPTOME ATLAS OF HAEMATOPOIESIS ACROSS THE HUMAN LIFESPAN2
3167 – NOTCH3 C455R EXPRESSION IN THE MURINE HEMATOPOIETIC SYSTEM RESULTS IN CLONAL HAEMATOPOIESIS AND A PERTURBED INFLAMMATORY MILIEU2
Back to the future: lessons from development drive innovation of human pluripotent stem cell therapies2
3200 – USING QUANTITATIVE PROTEOMICS TO IDENTIFY NEW THERAPEUTIC TARGETS IN MANTLE CELL LYMPHOMA2
3080 – RHOA SIGNALING IS REQUIRED FOR THE COLD-INDUCED PLATELET LESION AND REVERSIBLE TARGETING OF RHOA IN A NEW PLATELET ADDITIVE SOLUTION EXTENDS DONOR-DERIVED PLATELET SHELF-LIFE TO FOURTEEN DAYS.2
3128 – HYALURONIC ACID- GPRC5C SIGNALLING PROMOTES DORMANCY IN HEMATOPOIETIC STEM CELLS2
3220 – DEVELOPMENTAL TIMING OF ENDOTHELIAL GENE EXPRESSION REGULATES HUMAN HEMATOPOIESIS FROM INDUCED PLURIPOTENT STEM CELLS2
Physiological and regenerative functions of sterile-α motif protein-14 in hematopoiesis2
3155 – GENOME WIDE CRISPR/CAS9 KNOCKOUT SCREEN IN VIVO IDENTIFY GATOR1 COMPONENTS AS TUMOR SUPPRESSORS IN Eµ-MYC LYMPHOMAGENESIS2
3216 – GENOTOXIC FORMALDEHYDE ACCELERATES AGEING IN HEMATOPOIETIC STEM CELLS IN A P53-DRIVEN MANNER2
3012 – IL-27 REGULATES MONOCYTE DEVELOPMENT AND FUNCTION DURING ACUTE TOXOPLASMA GONDII INFECTION2
3150 – DYSREGULATION OF PHF6 FUNCTION IN ACUTE MYELOID LEUKEMIA2
3005 – MEGAKARYOCYTE-DERIVED PF4 SIGNALS VIA LDLR TO INHIBIT LEUKEMIA STEM CELL PROLIFERATION2
3153 – NON-CANONICAL EZH2 DRIVES RESISTANCE IN ACUTE MYELOID LEUKEMIAS2
3152 – HSC NICHE MOLECULAR DECONVOLUTION TOWARD IMPROVED UNDERSTANDING OF INTRINSIC AND EXTRINSIC HSC REGULATION2
3090 – HEMATOPOIETIC STEM AND PROGENITOR CELL VESICLES PRE-CONDITION THE BONE MARROW NICHE DURING TRANSPLANTATION2
3217 – KLF1-RELATED PROTEINS IN ERYTHROBLAST ISLAND MACROPHAGES – A PROTEOMIC STUDY2
3187 – SINGLE-CELL LINEAGE TRACING AND CLONAL DYNAMIC ANALYSIS OF HEMATOPOIETIC STEM CELL CLONES2
Author Index2
3112 – RETINOIC ACID AND ASCORBATE REMODEL THE EPIGENOME OF LEUKEMIA CELLS TO IMPROVE THERAPEUTIC EFFICACY BY ENHANCING TET ACTIVITY2
3207 – GENETIC IRON OVERLOAD EXACERBATES AND PHARMACOLOGICAL IRON RESTRICTION IMPROVES MDS PATHOPHYSIOLOGY IN PRECLINICAL STUDIES2
3232 – TARGETING SOD1 INDUCES SYNTHETIC LETHAL KILLING OF PPM1D-MUTANT LEUKEMIA CELLS2
3126 – RUNX FACTORS REGULATE EX VIVO HAEMATOPOIETIC STEM CELL EXPANSION2
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib2
3016 – MYCT1 CONTROLS HUMAN HEMATOPOIETIC STEM CELL FUNCTION BY MODERATING ENDOCYTOSIS AND ENVIRONMENTAL SENSING2
2001 – EMBRYONIC MACROPHAGES REGULATE THE SIZE OF THE DEFINITIVE HSC POOL2
3204 – INFLUENCE OF THE CXCL12/CXCR4 SIGNALING AXIS ON B CELL DEVELOPMENT, MATURATION AND FUNCTION2
3125 – ANTIFUNGALS CLOTRIMAZOLE AND ECONAZOLE NITRATE EFFECTIVELY TARGET A METABOLIC VULNERABILITY OF PAEDIATRIC ACUTE MYELOID LEUKAEMIA (PAML) WITH CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN VITRO.2
3059 – UNRAVELLING HUMAN HEMATOPOIETIC PROGENITOR CELL DIVERSITY THROUGH ASSOCIATION WITH INTRINSIC REGULATORY FACTORS2
3211 – MULTIOMIC ANALYSIS OF BONE MARROW HEMATOPOIETIC STEM/PROGENITOR CELLS REVEALS A POTENTIAL EARLY STAGE OF MALIGNANCY OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL2
3231 – PERSONALIZED HUMAN OSSICLES FOR THE ADVANCED IN VIVO MODELLING OF ACUTE MYELOID LEUKEMIA2
3227 – STAG2-COHESIN LOSS ATTENUATES FLT3ITD MYELOID BLAST EXPANSION YET PRESERVES MUTANT HSCS2
3103 – INHIBITING MAST CELL FUNCTION TO PROMOTE HEMATOPOIETIC REGENERATION FOLLOWING INJURY2
3193 – METABOLIC REGULATION OF NEUTROPHIL BIOLOGY IN A MURINE MODEL OF SEVERE MALNUTRITION2
3146 – THE ‘NON-ESSENTIAL’ AMINO ACID CYSTEINE IS REQUIRED TO PREVENT FERROPTOSIS IN ACUTE MYELOID LEUKEMIA2
3230 – RUNX1+23 ENHANCER REPORTER MARKS ERYTHRO-MEGAKARYOCYTE LINEAGE IN HUMAN ESC DIFFERENTIATION CULTURE2
3188 – EARLY DETECTION AND TREATMENT STRATEGIES FOR SRSF2-MUTANT CLONAL HEMATOPOIESIS2
3229 – MOZ/ENL COMPLEX IS A THERAPEUTIC TARGET FOR AF10-REARRANGED LEUKEMIA2
3010 – MOLECULAR DETERMINANTS OF INNATE IMMUNE SIGNAL-DEPENDENT GENOME RESPONSIVENESS IN HEMATOPOIETIC PROGENITOR CELLS2
1012 – A NOVEL HUMAN INFLAMMATORY MEMORY HSC LINKED TO INFECTION, AGING, AND CLONAL HEMATOPOIESIS2
2019 – DURING AGEING, THE HEMATOPOIETIC STEM CELL GENOME IS PROTECTED BY DORMANCY, NOT APOPTOSIS.1
A new era of functional experimentation in human hematopoiesis and leukemia research1
Extracellular vesicles tell all: How vesicle-mediated cellular communication shapes hematopoietic stem cell biology with increasing age1
Understanding genetic heterogeneity in gene-edited hematopoietic stem cell products1
3049 – VASCULAR CELL ADHESION MOLECULE-1 REGULATES BONE MARROW MESENCHYMAL STEM CELL MAINTENANCE AND NICHE FUNCTION1
IFC Editorial Board1
1015 – TARGETING ABERRANT SPLICING IN PEDIATRIC ACUTE MYELOID LEUKEMIA1
Molecular Basis of Hematological Disease Caused by Inherited or Acquired RUNX1 Mutations1
Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma1
FT-4202, a selective pyruvate kinase R activator for sickle cell disease1
Single-cell analysis of cultured bone marrow stromal cells reveals high similarity to fibroblasts in situ1
Experimental hematology transitions forward again with new leadership and great expectations1
3005 – DISTINCT ROLES OF YOLK SAC-DERIVED MYELOID CELLS IN FETAL HEMATOPOIESIS1
Chronic inflammation promotes cancer progression as a second hit1
Stayin’ alive: BCL-2 proteins in the hematopoietic system1
Targeting positive cofactor 4 induces autophagic cell death in MYC-expressing diffuse large B-cell lymphoma1
Chromothripsis in hematologic malignancies1
Cover 2: Editorial Board1
The hematopoietic stem cell expansion niche in fetal liver: Current state of the art and the way forward1
Capturing embryonic hematopoiesis in temporal and spatial dimensions1
Metabolic regulation in erythroid differentiation by systemic ketogenesis in fasted mice1
1021 – DIFFERENTIATION ROUTE DETERMINES THE FUNCTIONAL OUTPUTS OF ADULT MEGAKARYOPOIESIS1
Human pluripotent stem cell–derived hematopoietic progenitors and mature cells1
Amyloid deposition through endocytosis in vascular endothelial cells1
Cover 2: Editorial Board1
3009 – APELIN-MEDIATED CLONAL EXPANSION OF NICHE ENDOTHELIAL CELLS DRIVES SELECTION OF LEUKEMIC AND NORMAL HSC CLONES1
3161 – CELLULAR AND MOLECULAR EFFECTS OF DMPGE₂ RADIOMITIGATION IN MOUSE AND HUMAN BONE MARROW CELLS IN VIVO USING C57BL/6 AND HUMANIZED NSG MOUSE MODELS OF ACUTE RADIATION SYNDROME1
3116 – MITOCHONDRIAL FUSION AGONISTS IMPROVE EXPANDED CORD BLOOD HEMATOPOIETIC STEM AND PROGENITOR CELLS FUNCTION IN VIVO1
IFC Editorial Board1
3064 – ALKBH5 MODULATES HEMATOPOIETIC STEM AND PROGENITOR CELL ENERGY METABOLISM THROUGH M6A MODIFICATION-MEDIATED RNA STABILITY CONTROL1
Human umbilical cord mesenchymal stem cells ameliorate acute graft-versus-host disease by elevating phytosphingosine1
A novel Kit mutant rat enables hematopoietic stem cell engraftment without irradiation1
Platelet ultrastructural changes stored at room temperature versus cold storage observed by electron microscopy and structured illumination microscopy1
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs1
3001 – STRESS-SPECIFIC ERYTHROID PROGENITORS IN REGENERATIVE ERYTHROPOIESIS AND MYELOPROLIFERATIVE NEOPLASM1
Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome1
Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage1
1022 – ADVANCES IN CELLULAR BARCODING: EXPLORING HEMATOPOIETIC STEM CELLS AGEING AND METABOLIC FUNCTIONS IN LINEAGE SPECIFICATION1
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation1
Reconsidering the usual suspects in age-related hematologic disorders: is stem cell dysfunction a root cause of aging?1
1024 –1
Corrigendum to <‘Novel therapeutic strategies for multiple myeloma’> <[Experimental Hematology 2015; 43: 732-741]>1
O-GlcNAcylation: Implications in normal and malignant hematopoiesis1
Mitochondria in human acute myeloid leukemia cell lines have ultrastructural alterations linked to deregulation of their respiratory profiles1
Making blood: Mechanisms of early hematopoietic development1
Ex vivo modelling reveals low levels of CKS1 inhibition boost haematopoiesis via AKT/Foxo1 signalling1
Pseudogenes and their potential functions in hematopoiesis1
3125 – IDENTIFICATION OF CULTURE CONDITIONS THAT SUSTAIN THE IN VIVO REGENERATIVE PROPERTIES OF A NEW SUBSET OF HUMAN FETAL LIVER HEMATOPOIETIC STEM CELLS1
3014 – MEAN PLATELET VOLUME - A NOVEL BIOMARKER IN VARIOUS CARDIOVASCULAR DISEASES1
IFC Editorial Board1
3096 – FUNCTIONAL HSCS PREFERENTIALLY MIGRATE TO SPLEEN DURING HEMATOPOIETIC REGENERATION1
Biomarkers for aging of blood – how transferable are they between mice and humans?1
3023 – ATLAS-AML: AN AUTOMATED BIOINFORMATICS PIPELINE FOR TARGET CHARACTERIZATION IN ACUTE MYELOID LEUKEMIA1
Corrigendum to ‘3161 – CELLULAR AND MOLECULAR EFFECTS OF DMPGE₂ RADIOMITIGATION IN MOUSE AND HUMAN BONE MARROW CELLS IN VIVO USING C57BL/6 AND HUMANIZED NSG MOUSE MODELS OF ACUTE RADIATION SYNDROME’ [1
3085 – SETD1A FUNCTION IS MEDIATED THROUGH INTERACTION WITH MITOTIC REGULATORS BUGZ/BUB3 IN LEUKEMIA1
Cover 2: Editorial Board1
A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination re1
Differential impact of CD34+ cell dose for different age groups in allogeneic hematopoietic cell transplantation for acute leukemia: a machine learning–based discovery1
G-CSF–induced hematopoietic stem cell mobilization from the embryonic hematopoietic niche does not require neutrophils and macrophages1
1030 – CELLULAR AND MOLECULAR MECHANISMS OF HEMATOPOIETIC LINEAGE CHOICE1
The critical role of the bone marrow stromal microenvironment for the development of drug screening platforms in leukemia1
1023 – UNIQUE CONFIGURATION OF THE PROTEOSTASIS NETWORK BALANCES HEMATOPOIETIC STEM CELL FITNESS AND LONGEVITY1
Cover 2: Editorial Board1
Chronic murine schistosomiasis causes aberrant hemostasis1
Radiation-free reduced-intensity hematopoietic stem cell transplantation with in vivo T-cell depletion from matched related and unrelated donors for Fanconi anemia: prognostic factor analysis1
Harnessing Single-Cell Technologies in the Search for New Therapies for Diamond–Blackfan Anemia Syndrome1
Mechanistic and kinetic insights into transcription factor biology via acute protein depletion1
Human, mouse, and dog bone marrow show similar mesenchymal stromal cells within a distinctive microenvironment1
Extraembryonic hematopoietic lineages—to macrophages and beyond1
Hematopoietic stem and progenitor cells outside the bone marrow: where, when, and why1
To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice1
Understanding Human Oncogene Function and Cooperativity in Myeloid Malignancy Using iPSCs1
0.12767910957336